Fereshteh Saddadi
1 
, Bahareh Marghoob
1* , Mohamadhasan Fallahkohan
2 1 Hashemi Nejad Kidney Center (HKC), Iran University of Medical Sciences (IUMS), Tehran, Iran
2 Shahid Beheshti Medical University (SBMU), Tehran, Iran
Abstract
The kidneys are one of the main organs which involved in light chain deposition disease (LCDD). The usual renal presentations are renal failure with or without nephrotic range proteinuria and microscopic hematuria. There is not a standard therapy of kidney involvement in this disease which named as monoclonal gammopathy of renal significance (MGRS). The present case is focused on a new therapeutic strategy.
Implication for health policy/practice/research/medical education:
Monoclonal gammopathy of renal significance is a new diagnostic terminology which demonstrates patients with kidney disease due to monoclonal proteins whose clinical course does not fulfill the criteria for multiple myeloma.
Please cite this paper as: Saddadi F, Marghoob B, Fallahkohan M. Light chain deposition disease as monoclonal gammopathy of renal significance-a rare disease with scarce therapy; a case report. J Nephropathol. 2024;13(4):e25550. DOI: 10.34172/jnp.2024.25550.